Author | Jason A. Konner, MD | OncLive

Author | Jason A. Konner, MD


Dr. Konner on Preferred Platinum Doublets in Recurrent Ovarian Cancer

May 18, 2019


Jason A. Konner, MD, medical oncologist, Memorial Sloan Kettering Cancer, discusses preferred platinum doublet chemotherapies in the treatment of patients with recurrent ovarian cancer.

Dr. Konner Discusses PARP Inhibitors in Ovarian Cancer

February 04, 2013


Jason A. Konner, MD, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses the uncertain path of PARP inhibitors for the treatment of ovarian cancer.

Dr. Konner on Bevacizumab in Ovarian Cancer

November 16, 2012


Jason A. Konner, MD, from Memorial Sloan-Kettering Cancer Center, explains that one of the main drivers behind research into bevacizumab in ovarian cancer is to identify which patients will benefit the most from the treatment.